Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis A Phase III Randomized Trial (MEASURE 1)

Atul A. Deodhar, Maxime Dougados, Dominique L. Baeten, James Cheng-Chung Wei, Piet Geusens, Aimee Readie, Hanno B. Richards, Ruvie Martin, Brian Porter

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)2901-2910
JournalArthritis & Rheumatology
Volume68
Issue number12
DOIs
Publication statusPublished - Dec 2016

Cite this

Deodhar, A. A., Dougados, M., Baeten, D. L., Wei, J. C-C., Geusens, P., Readie, A., Richards, H. B., Martin, R., & Porter, B. (2016). Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis A Phase III Randomized Trial (MEASURE 1). Arthritis & Rheumatology, 68(12), 2901-2910. https://doi.org/10.1002/art.39805